定量的な感受性のマッピングは,ルイ体の認知症のサブタイプ間の違いを明らかにします
Rohan Bhome1,2, George E C Thomas1, Naomi Hannaway1
1Dementia Research Centre, University College London, London, WC1N 3AR, UK.
Brain : a journal of neurology
|September 4, 2025
まとめ
定量的な感受性マッピング (QSM) は,ルイ体の認知症 (DLB) とパーキンソン病の認知症 (PDD) の間の鉄分差異を明らかにします. これらの発見は,DLBとPDDは異なる状態であり,標的治療とバイオマーカーとしてのQSMから潜在的に恩恵を受けることを示唆しています.
科学分野:
- 神経イメージング
- 神経学
- バイオマーカーの発見
背景:
- ルイ体の認知症 (DLB) とパーキンソン病の認知症 (PDD) は,ルイ体の認知症のサブタイプであり,しばしば疾患スペクトルで見られます.
- 従来のMRIは DLBとPDDの間の神経生物学的なプロセスを区別するのに敏感ではありません.
- 亜型特有の差異を特定することは,ルイ体の認知症の標的治療の開発に不可欠です.
研究 の 目的:
- 定量感受性マッピング (QSM) を使用してDLBとPDDの神経生物学的な違いを調査する.
- ルイ体の認知症のサブタイプと疾患の重度のイメージングバイオマーカーとしてのQSMの可能性を評価する.
- QSM値,認知能力,全体的な疾患の重症度との関係を調べる.
主な方法:
- 定量的な感受性マッピング (QSM) は,ルイ体の認知症 (45 DLB,21 PDD),パーキンソン病と正常な認知 (PD- NC) を有する86人,そして37人の健康な対照群に適用された.
- 脳の各領域のQSM値を比較するために,ヴォクセルと関心領域 (ROI) の分析が行われました.
- QSM値と臨床測定値 (認知機能,運動障害学会統一パーキンソン病評価尺度) の関係が評価された.
主要な成果:
- Lewy体認知症の個人は,PD-NCと比較して,広範囲の脳領域で高いQSM値を示しました.
- PDDは,多くの脳の領域,特に黒い部分の reticulataにおいて,DLBよりも著しく高いQSM値を示しました.
- QSM値の上昇は,DLBとPDDの患者における全疾患の重症度と好意的に相関していた.
結論:
- QSMは DLBとPDDの間に 明確な神経生物学的な違い,特に鉄の堆積パターンを検出します.
- DLBとPDDは異なる臨床実体であり,サブタイプ特有の治療戦略と臨床試験の設計を正当化しています.
- QSMは,ルイ体の認知症の臨床試験における疾患の重度および進行を評価するための敏感なイメージングバイオマーカーとして有望である.
関連する概念動画
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


